Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Cryoablation

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT05820035Not ApplicableCompleted

A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia

NCT01426425Phase 3CompletedPrimary

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

NCT06492499CompletedPrimary

Patient-Centric Innovation: Superior Vena Cava Approach in Zero-Fluoroscopy

NCT01584154Phase 4Unknown

Comparative Study Between Cryoablation and Radiofrequency Ablation in the Treatment of Supraventricular Tachycardia

Showing all 4 trials

Research Network

Common Treatments

  • Cryoablation1
  • Radiofrequency Ablation1
  • Zerofluoroscopy Radiofrequency Catheter Ablation1
  • Freezor Xtra Cryoablation Catheter1
  • Pulsed Field Ablation Device And Cfsensing Pulsed Field Ablation Catheter1

Active Sponsors

  • Shanghai MicroPort EP MedTech Co., Ltd.1
  • Ning Zhou1
  • Princess Margaret Hospital, Hong Kong1
  • Medtronic Cardiac Ablation Solutions1

Top Investigators

Related Conditions

  • Supraventricular Tachycardia2
  • Heart Disease1
  • Paroxysmal Supraventricular Tachycardia1
  • Atrioventricular Reciprocating Tachycardia1

Activity Timeline